BACKGROUND: The -174G/C polymorphism in interleukin 6 (IL-6) gene has been extensively investigated for association to Alzheimer's disease (AD); however, results of different studies have been inconsistent. The objective of this study is to assess the relationship of IL-6 -174G/C polymorphism and Alzheimer's disease (AD) risk by using meta-analysis. METHODS: All eligible case-control studies were searched in PubMed and EMBASE. Odds ratios (ORs) with the 95% confidence intervals (CIs) were used to assess the association. RESULTS: A total of 5316 cases and 10 757 controls in 21 case-control studies were included. Obvious heterogeneity among studies was detected, and no significant association was observed between the IL-6 -174G/C polymorphism and AD risk. After exclusion of three studies, the heterogeneity disappeared and significant association was observed between the polymorphism and AD risk in Asians (CC vs. CG+GG: OR = 0.5; 95%CI, 0.33-0.75) but not in Caucasians. CONCLUSION: This meta-analysis suggested that the -174G/C polymorphism of IL-6 gene would be a protective risk factor for AD in Asians. To further evaluate gene-to-gene and gene-to-environmental interactions between polymorphisms of IL-10 gene and AD risk, more studies with large groups of patients are required.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: